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Abstract
Background: Antimicrobial resistance (AMR) is an increasing public health problem worldwide.
We studied some patient-related factors that might influence the antimicrobial resistance.
and whether the volume of antibiotic prescribing of the primary care physicians correlate with the antibiotic
resistance rates of commensal nasal Staphylococcus aureus and Streptococcus pneumoniae.
Methods: The socio-demographic questionnaires, the antibiotic prescription and resistance data of commensal
nasal S. aureus and S. pneumoniae were collected in the 20 participating Hungarian practices of the APRES study.
Multivariate logistic regression analyses were performed on the patient-related data and the antimicrobial resistance
of the S. aureus and S. pneumoniae on individual, patient level.
Ecological analyses were performed with Spearman’s rank correlations at practice level, the analyses were
performed in the whole sample (all practices) and in the cohorts of primary care practices taking care of adults
(adult practices) or children (paediatric practices).
Results: According to the multivariate model, age of the patients significantly influenced the antimicrobial
resistance of the S. aureus (OR = 0.42, p = 0.004) and S. pneumoniae (OR = 0.89, p < 0.001). Living with children
significantly increased the AMR of the S. pneumoniae (OR = 1.23, p = 0.019). In the cohorts of adult or paediatric
practices, neither the age nor other variables influenced the AMR of the S. aureus and S. pneumoniae.
At practice level, the prescribed volume of penicillins significantly correlated with the resistance rates of the S.
aureus isolates to penicillin (rho = 0.57, p = 0.008). The volume of prescribed macrolides, lincosamides showed
positive significant correlations with the S. pneumoniae resistance rates to clarithromycin and/or clindamycin in all
practices (rho = 0.76, p = 0.001) and in the adult practices (rho = 0.63, p = 0.021).
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Conclusions: The age is an important influencing factor of antimicrobial resistance. The results also suggest that
there may be an association between the antibiotic prescribing of the primary care providers and the antibiotic
resistance of the commensal S. aureus and S. pneumoniae. The role of the primary care physicians in the
appropriate antibiotic prescribing is very important to avoid the antibiotic resistance.
Keywords: Antimicrobial resistance, Antibacterial resistance, Commensal, Healthy population, Patient-related factors,
Staphylococcus aureus, Streptococcus pneumoniae
Background
Antimicrobial resistance (AMR), in particular antibacterial
resistance (ABR) is an increasing public health problem
worldwide [1]. The available antibiotics might become in-
effective against infections due to antimicrobial resistance,
although there is a continuous research and development
of new antibiotics. There are only a limited number of
new antibiotics available in primary care [2], so avoiding
resistance with all the possible means is very important.
About 90% of the antibiotics are prescribed by primary
care providers [3, 4].
It has been shown that the overuse of antibiotics in-
creases the risk of side effects, raises costs and is associ-
ated with increased AMR levels [5]. The resistance rates
of the bacteria are influenced by prescribers’ prescribing
habits and by health policies as well [6].
Higher prescribing rates of antibiotics may increase the
resistance in individuals, on the community level and in
the whole society [7–9]. The results of the analysis of the
outpatient antibiotic use and resistance in 26 countries in
Europe showed significant correlation between increased
consumption of antibiotics and the resistance of the mi-
croorganisms at national level [3].
Antibiotic use is a major contributing factor to the
development of resistant bacteria, but many other
factors may contribute: e.g. patients’ age, movement
and migration, socio-economic factors, dose and dur-
ation of the antibiotic treatment, gene transfer and
clonal spread [10]. Human beings carry a very large
number of commensal organisms which probably
provide a significant but underestimated reservoir of
resistance genes [11]. How these influence the devel-
opment of resistance in pathogenic organisms is as
yet uncertain [12].
The APRES study (The Appropriateness of PRE-
Scribing antibiotics in primary health care in Europe
with respect to antibiotic resistance) was designed to
establish resistance patterns of Staphylococcus aureus
and Streptococcus pneumoniae in the nasal flora in
community-dwelling individuals and to collect data
about the antibiotic prescribing patterns of primary
care providers (family physicians/general practitioners,
primary care paediatricians) in nine European coun-
tries, the project was closed in 2014 [9, 13, 14].
The results of the APRES study in other countries sug-
gest that age is one of the major determining factors of
the prevalence of S. aureus carriership, but there may be
also other factors that influence the nasal carriage [15, 16].
Another previously published result of the APRES
study suggests that higher resistance rates of S. aureus
are associated with younger age, but also the primary
care physicians’ antibiotic prescribing behaviour may in-
fluence the odds of the carriage of the resistant nasal
commensal S. aureus and there is a need for further
investigations on a national level [17].
The antibiotics are prescription only medicines, that can
only be prescribed by doctors in Hungary. The national
total antibiotic consumption was relatively constant be-
tween 1996 and 2003, but there were large differences
between the community antibiotic consumption of the
regions and between counties [18, 19]. Other previously
published Hungarian studies about the ambulatory
antibiotic consumption established a constant quantity
(18.0 ± 1.8 DDD/1000 inhabitants/day) between the years
2006–2010 [20].
Primary care practices are usually the first point of access
to health care in Hungary. There are about 6500 primary
care (PC) practices for a population of approximately 10
million in Hungary. There are three main types of PC prac-
tices in Hungary: adult practices (n ≈ 3500) treating adults
only, paediatric practices (n ≈ 1500) with primary care pae-
diatricians mostly in bigger towns and cities, caring of chil-
dren under 18 years only, and mixed practices (n ≈ 1500)
treating people of all ages (mainly established in smaller
settlements, villages) [21].
The antimicrobial resistance at younger patients may
be higher and the primary care providers antibiotic
prescribing may influence the resistance rates of the
commensal S. aureus and S. pneumoniae, we found no
previous publications that investigated the antimicrobial
resistance of two commensal bacteria at individual and
at primary care practice level.
The aim of this study was to investigate, based on the
Hungarian data of the APRES Study:
1. The patient-related factors that may influence the
antimicrobial resistance of the commensal S. aureus
and S. pneumoniae at patient level.
Kolozsvári et al. BMC Infectious Diseases          (2019) 19:253 Page 2 of 8
2. Whether the volume of antibiotic prescribing of
primary care providers correlate with the antibiotic
resistance rates at practice level.
Methods
The APRES study design was published in previous
articles in detail [13, 14], we therefore mainly focus on
the methodology related to our study.
Patients and practices
Socio-demographic data of the participating patients (eg.
age, gender, living with children, number of GP visits
during the previous year etc.) and data of the practices
(e.g. number of registered patients, practice type etc.)
were collected with questionnaires.
The Hungarian part of the study was conducted in 20
primary care practices, patients were selected in all 3
types of Hungarian primary care practices (13 adult, 5
paediatric and 2 mixed practices) between November
2010 and March 2011.
The number of participating patients and primary care
practices were calculated and established by an inter-
national group of experts and included in the APRES
Study protocol [13, 14].
The participating practices were located in 5 counties
(Borsod-Abaúj-Zemplén, Csongrád, Hajdú-Bihar, Heves,
Szabolcs-Szatmár-Bereg) and in the capital (Budapest).
The practice locations represented the main types of set-
tlements across Hungary: the capital (1), larger cities
(10), towns (5), large village (1) and villages (3 practices).
Bacterial specimens
Bacterial specimens were collected from a random sam-
ple of persons over 4 years of age, who attended the
primary care practices and had no symptoms of an in-
fectious disease. Other exclusion criteria were antibiotic
use or hospitalisation in past 3months, severe health
problems (terminal illness, immunocompromised).
Nasal swabs were obtained from the individuals ac-
cording to a routine protocol. The specimens were im-
mediately inserted into a container tube, with charcoal
transport medium and transferred into the Department
of Medical Microbiology at the University of Debrecen
within 48 h. Colonies with characteristic Staphylococcus
morphology were identified as S. aureus based on posi-
tive coagulase test and colonies of S. pneumoniae were
identified on the basis of colony morphology and resistance
to optochin by the national laboratory, then transferred and
tested for resistance against antibiotics in one central la-
boratory (Maastricht University). Both S. aureus and S.
pneumoniae isolates were stored in frozen skimmed milk
under liquid nitrogen until transporting them to Maastricht
University where antibiotic resistance were established
quantitatively with a broth dilution method in micro-titre
plates according to EUCAST recommendations [13, 22].
The S. aureus and S. pneumoniae isolates were tested for
the following antimicrobials: penicillins with and without
beta-lactamase inhibitors, cephalosporines, macrolides, tet-
racyclines, quinolones, trimethoprim-sulfamethoxazole and
rifampicin; for S. aureus also aminoglycosides, fusidic acid
and mupirocin were tested [13, 14].
Resistance was considered present if there was resist-
ance to one or more antibiotic (R ≥ 1). Furthermore, we
considered the resistance rates to penicillin (J01C) and
azithromycin and/or clindamycin (J01F) specifically. The
resistance rates were also calculated in cohorts of prac-
tices (all practices, adult practices, paediatric practice).
Antibiotic prescribing
The antibiotic prescribing data were collected from the 20
primary care physicians’ computer databases. All individ-
ual antibiotic prescriptions were classified by the active
substance according to anatomic therapeutic classification
(ATC), DDD (Defined Daily Dose), DPP (dose per pack-
age) and number of packages. In our study, the antibiotic
prescribing of the primary care practices was expressed in
DDD/1000 active patients/day, according to the WHO
ATC/DDD methodology [23]. The antibiotic exposure
was measured with the DDDs (not the number of pack-
ages), because this may be more appropriate for inter-
national and national comparison and to evaluate the
correlation between the use of antibiotics and antimicro-
bial resistance [4, 24, 25]. There are opinions, that the
main effect of the prescribed antibiotics to the resistance
rates may last for up to one year, so we considered the
prescribing data the year preceding the nasal sampling, in
2010 [8, 17, 26].
Statistical analysis
Multivariate logistic regression models were performed
on the patient-related data and the antimicrobial resist-
ance (isolates that were resistant to at least one antibi-
otics, R ≥ 1) of the S. aureus and S. pneumoniae on
individual, patient level. The association between the S.
aureus and S. pneumoniae antimicrobial resistance (out-
come/dependent variables) and the patient- related fac-
tors (explanatory/independent variables) were analysed.
The patient-related factors (independent variables) were
patients’ age (years), gender (female/male), job (working
with livestock and/or in nursery and/or in healthcare), liv-
ing with children (yes/no), number of GP visits during the
previous year (1–4 visits/none, 5 + visits/none). The ana-
lyses were performed in the whole sample (all practices)
and in the cohorts of practices taking care of adult persons
(adult practices) or children only (paediatric practices).
Due to the data collection methods and anonymous pa-
tient data, the antimicrobial resistance and individual anti-
biotic prescribing data could not be linked at individual
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level, this was one the reasons why we investigated the
correlation between the antibiotic prescribing and resist-
ance rates at practice level. The resistance rates were also
calculated at practice level. We presumed that the most
commonly prescribed antibiotics groups in primary
care are the penicillins (Beta-lactam antibacterials,
penicillins J01C) and macrolides (Macrolides, lincosa-
mides and streptogramins J01F). Furthermore, we con-
sidered the resistance rates to penicillin (J01C) and
azithromycin/clarithromycin and/or clindamycin (J01F)
specifically. The associations between the usage of antibi-
otics (DDD/1000 patients/day) and the resistance rates
were analysed by Spearman’s rank correlation. The corre-
lations were analysed in the whole sample (all practices)
and we also calculated the correlation in the cohorts of
adult practices and paediatric practices.
The statistical analyses were performed with STATA
11.1 software (Statacorp LP. College Station, TX, USA).
Results
Patients and practices
There were 4017 questionnaires collected from the par-
ticipating patients. The age distribution of the partici-
pants was 4–19 years: 28.2%, 20–64 years: 50.4%, and
above 65 years: 21.3%. Their gender distribution was
44.5% male (n = 1713), 55.5% female (n = 2137).
The average number of registered patients was 1905
persons per practice (range between 724 and 3308). The
adult practices had 2219 registered patients on average,
the mixed practices 1719 and the paediatric practices
1163 patients on their list in year 2010, respectively.
The number of active patients (patients who attended
the primary care surgery at least once in 2010) was used
as denominator in our ecological statistical analyses. The
average number of active patients was 1534 persons per
practice (range between 658 and 1976). On average,
there were 1758 active patients in the adult, 1227 in the
mixed practices and 1057 in the paediatric practices seen
in year 2010, respectively.
Bacterial specimens
There were 4017 nasal swabs collected, the number of
the incorrect sampling was 150 (absence of bacteria, in-
cluding normal microbiota), the number of mismatched
samples were 17 (absence of patient background infor-
mation or laboratory data). 3850 swabs were tested in
the laboratory, including 2471 swabs from the adult and
984 in the paediatric practices.
The prevalence of carrying commensal S. aureus was
14.1% in all practices (n = 541), 12.8% in adult practices
(n = 317) and in 17.6% paediatric practices (n = 173). The
prevalence of the S. pneumoniae was 4.1% in all prac-
tices (n = 159), 1.1% in adult practices (n = 28) and 12.1%
in paediatric practices (n = 119).
The number and percentage of resistant isolates are
shown in Table 1.
According to our descriptive statistics, the prevalence
of antimicrobial resistance (resistance to one or more
antibiotics (R ≥ 1) and resistance against penicillins
(J01C) and macrolides/lincosamides (J01F) of the S. aur-
eus and S. pneumoniae seemed to be lower in the co-
horts of adult practices and higher in the paediatric
practices, comparing to the cohorts of all practices.
Antibiotic prescribing
There were 24,223 antibiotic prescriptions issued by the
participating primary care providers in 2010. The aver-
age volume of all prescribed antibiotics was 15.86 DDD/
1000 active patients/day per practice, the most commonly
prescribed antibiotics were the beta-lactam antibacterials,
penicillins (ATC3 level J01C; 8.61 DDD/1000 active pa-
tients/day per practice), the macrolides/lincosamides (J01F;
3.47), the other beta-lactam antibacterials (J01D; 1.37); the
quinolone antibacterials (J01M; 1.17), the tetracyclines
(J01A; 0.51), the sulphonamides and trimethoprim
(J01E; 0.42), and the other antibacterials (J01X; 0.98).
The mean volume of the prescribed penicillins (J01C) was
8.86 ± 1.8 (mean ± SD) DDD per 1000 active patients/day in
all practices, 4.96 ± 2.74 DDD per 1000 active patients/day
in the adult practices. The mean volume of the prescribed
macrolides/lincosamides (J01F) was 3.43 ± 2.39 DDD per
1000 active patients/day in all practices, 2.79 ± 1.17 DDD
per 1000 active patients/day in the adult practices.
Patient-related factors and antimicrobial resistance of the S.
aureus and S. pneumoniae
The age of the patients significantly influenced the resist-
ance of the S. aureus and S. pneumoniae. The odds having
antimicrobial resistance decreased in the group of the pa-
tients over 18 years of age (ORS.aureus = 0.42, p = 0.004;
ORS.pneumoniae = 0.89, p < 0.001). Living with children
significantly increased (OR = 1.23, p = 0.019) the AMR of
the S. pneumoniae.
Table 1 The resistance of S. aureus and S. pneumoniae in all
practices, adult practices and paediatric practices
Resistance All practices Adult practices Paediatric practices
S. aureus n = 541 n = 317 n = 173
R≥ 1 434 (80.2%) 237 (74.8%) 151 (87.3%)
J01C 410 (75.8%) 221 (69.7%) 145 (83.8%)
J01F 65 (12.0%) 32 (10.1%) 28 (16.2%)
S. pneumoniae n = 159 n = 28 n = 119
R≥ 1 112 (70.4%) 10 (35.7%) 95 (79.8%)
J01C 30 (18.9%) 3 (10.7%) 25 (21.0%)
J01F 18 (11.3%) 2 (7.1%) 15 (12.6%)
[R ≥ 1, resistance to one or more antibiotics; J01C resistance to penicillins; J01F
resistance to macrolides/lincosamides]
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It appears that in the cohorts of adult and paediatric
practices the age-related or other variables did not influ-
ence the AMR of S. aureus and S. pneumoniae (Table 2).
The correlation between antibiotic prescribing and
resistance rates
The volume of prescribed penicillins (J01C) correlated
significantly with the resistance rates of S. aureus isolates
to penicillin, when including the data from all practices
in the analyses (rho = 0.57, p = 0.008), this means a mod-
erate positive correlation, but not correlated when con-
sidering the adult (rho = 0.30, p = 0.319) or paediatric
(rho = 0.54, p = 0.284) practices only. There was no sig-
nificant correlation between the volume of prescribed
macrolides, lincosamides (J01F) and the S. aureus resist-
ance rates to azithromycin and/or clindamycin (Table 3).
The volume of prescribed macrolides, lincosamides
(J01F) showed strong positive significant correlation with
the S. pneumoniae resistance rates to clarithromycin and/
or clindamycin in all practices (rho = 0.76, p < 0.001) and
in the adult practices (rho = 0.63, p = 0.021), but no correl-
ation in the paediatric practices (rho = 0.52, p = 0.191).
The correlation between the volume of prescribed penicil-
lins (J01C) with the resistance rates of S. pneumoniae was
not statistically significant (Table 4.)
Discussion
The age of the patients may be an important factor
regarding antimicrobial resistance. However, when we
investigated the cohorts of both adult and paediatric
practices separately, there was no association between
the age and resistance. Living with children in a same
household is likely to increase the risk of having resist-
ant S. pneumoniae isolates. Childhood seems to be a
more important influencing factor than the age only, as
it could be concluded from the previous publications
[14, 16, 17]. The APRES Study, that studied apparently
healthy population revealed reduced prevalence of both
methicillin-sensitive and methicillin-resistant S. aureus
isolates with older age, but the prevalence and resistance
Table 2 Multivariate logistic regression models on the patient-related variables and antimicrobial resistance of the S. aureus and S.
pneumoniae
Variables S. aureus resistance
All practices Adult practices Paediatric practices
Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value
Patient variables
Age groups (over 18 years/under 18 years) 0.42 0.004 0.64 0.693 0.44 0.269
Gender (male/female) 0.79 0.322 0.92 0.765 0.42 0.083
Job - Livestock (yes/no) 0.91 0.970 1.01 0.980 N/A N/A
Job - Nursery (yes/no) 0.55 0.329 0.89 0.967 N/A N/A
Job - Healthcare (yes/no) 0.90 0.903 0.95 0.952 N/A N/A
Living with children (yes/no) 0.79 0.537 0.67 0.428 1.12 0.859
Number of GP visits
1–4 visits/none 0.60 0.528 0.77 0.757 0.11 0.969
5 + visits/none 0.90 0.898 1.18 0.859 0.10 0.971
Variables S. pneumoniae resistance
All practices Adult practices Paediatric practices
Odds Ratio p-value Odds Ratio p-value Odds Ratio p-value
Patient variables
Age groups (over 18 years/under 18 years) 0.89 < 0.001 1.00 0.842 0.79 0.785
Gender (male/female) 1.45 0.425 1.87 0.503 1.27 0.646
Job - Livestock (yes/no) 1.23 0.873 3.59 0.430 N/A N/A
Job - Nursery (yes/no) N/A N/A N/A N/A N/A N/A
Job - Healthcare (yes/no) 3.71 0.324 3.07 0.206 N/A N/A
Living with children (yes/no) 1.23 0.019 0.29 0.409 0.34 0.085
Number of GP visits
1–4 visits/none 0.98 0.988 1.37 0.962 1.08 0.933
5 + visits/none 0.98 0.925 0.93 0.409 1.03 0.978
[significant results marked in bold]
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differed between and within the participating countries
[14, 16, 17]. Methicillin-resistant S. aureus isolates from
patients with impaired health showed increasing fluoro-
quinolone resistance rate with patients’ age. The latter
phenomenon was however unique for fluoroquinolones
only and was not noticed for other antibiotics [27]. In
the healthy population, the resistance rates of different
age groups with recent history of increased antibiotic
load are likely different from the patients with impaired
health [14, 27].
The prescribed average volume of all prescribed antibi-
otics by the participating Hungarian physicians was 15.86
DDD/1000 active patients/day per practice in 2010. The
most commonly prescribed antibiotics were the beta--
lactam antibacterials, penicillins and the macrolides.
According to the data from the European Surveillance
of Antimicrobial Consumption (ESAC) project the
consumption of antibacterials for systemic use (ATC
group J01) was 15.67 DDD/1000 inhabitants/day in the
primary care sector in Hungary in 2010, this is compar-
able to the prescribed average volume of the antibiotics in
the cohort of the 20 practices in our study [4].
The nasal carriage of the commensal S. aureus and S.
pneumoniae were higher in the paediatric practices.
There were differences between the antimicrobial resist-
ance (resistance to one or more antibiotics - R ≥ 1) of S.
aureus and S. pneumoniae in the participating primary
care practices, the lowest resistance rates were found in
the cohort of the adult practices.
There may be an association between the volume of
prescribed antibiotics by primary care physicians and the
bacterial resistance rates, the results of the Spearman’s
rank correlation analysis suggested, that the primary
care providers’ antibiotic prescribing may correlate with
the antibiotic resistance of the commensal S. aureus
and S. pneumoniae.
Table 3 Correlations between volume of prescribed penicillins and macrolides/lincosamides and resistance rates of S. aureus (%) in
all practices, adult and paediatric practices
All practices
Prescription of S. aureus resistance to rho p-value
Penicillins (J01C) Penicillin 0.57 0.008
Macrolides, lincosamides (J01F) Azithromycin and/or clindamycin 0.22 0.343
Adult practices
Prescription of S. aureus resistance to rho p-value
Penicillins (J01C) Penicillin 0.30 0.319
Macrolides, lincosamides (J01F) Azithromycin and/or clindamycin 0.03 0.922
Paediatric practices
Prescription of S. aureus resistance to rho p-value
Penicillins (J01C) Penicillin 0.60 0.284
Macrolides, lincosamides (J01F) Azithromycin and/or clindamycin 0.54 0.391
(Spearman’s rank correlation) [significant results marked in bold]
Table 4 Correlations between volume of prescribed penicillins and clarithromycin and/or clindamycin and resistance rates (%) in all
practices, adult and paediatric practices
All practices
Prescription of S. pneumoniae resistance to rho p-value
Penicillins (J01C) Penicillin 0.39 0.084
Macrolides, lincosamides (J01F) Clarithromycin and/or clindamycin 0.76 0.001
Adult practices
Prescription of S. pneumoniae resistance to rho p-value
Penicillins (J01C) Penicillin 0.30 0.319
Macrolides, lincosamides (J01F) Clarithromycin and/or clindamycin 0.63 0.021
Paediatric practices
Prescription of S. pneumoniae resistance to rho p-value
Penicillins (J01C) Penicillin 0.10 0.872
Macrolides, lincosamides (J01F) Clarithromycin and/or clindamycin 0.52 0.191
(Spearman’s rank correlation) [significant results marked in bold]
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Strengths and limitations
There was large amount of information collected. The
average volume of the antibiotic prescribing by the partici-
pating practices in our study was similar to the previously
published Hungarian outpatient antibiotic prescribing
data, so the volume of antibiotic prescribing in the partici-
pating practices was likely representative for the Hungar-
ian practices [4, 19, 20]. Other strength of the study was
the large sample size of the questionnaires and nasal
swabs taken from a healthy population. The prevalence
and resistance rates were similar to previously published
data, but most studies investigated the resistance rates
from the hospital settings or from pathogen bacteria
[3, 8, 12]. There was no previous study found which
investigated the correlation between the antibiotic
prescribing of the primary care providers at practice
level and the antibiotic resistance of the commensal
flora. Previous publication from the APRES Study sug-
gested, that AMR could be associated with the anti-
biotic exposure in the primary care, it is important to
investigate the correlation between the GP practices
antibiotic prescribing and the prevalence and resist-
ance of the commensal bacteria on a national level, as
we done in our publication [17].
A limitation of the study was the relatively small num-
ber of the participating patients and practices, compar-
ing to the total number of primary care practices and to
the total population of Hungary, even though the ex-
pected number of the practices and participants per
country were analysed, calculated and established by an
international group of experts and included in the study
protocol. The sample was selected as a likely representa-
tive sample to the Hungarian primary care practices
[13]. The number of the incorrect sampling and the mis-
matched samples caused some loss of the prevalence
and resistance data. The low prevalence and antibacterial
resistance of the commensal S. pneumoniae made the
statistical analyses less powerful. The correlations in our
study does not necessarily imply causality.
The antimicrobial resistance can be affected by several
factors, some of them cannot be influenced (eg. age of
the patient), but there are factors, like the primary care
providers’ antibiotic prescribing, that can be influenced
by education, regulation of the prescribing, developing
and use of guidelines etc.
Antibiotic prescribing in the primary care practices
may influence the resistance of the commensal flora,
which could be a reservoir of resistance genes. Accord-
ing to previous studies, this resistance likely can be
transferred from the commensal flora to the pathogens
[10, 11]. Primary care providers prescribe large propor-
tions of the antibiotics; therefore, they have an important
role to prevent the spread of the antibiotic resistance. It
is very important that the healthcare providers only
should prescribe antibiotics only when it’s necessary and
when the antibiotic treatment is indicated. This can be
achieved with appropriate health policies, guidelines and
continuous education of the primary care physicians.
Conclusions
The age is an important influencing factor of antimicro-
bial resistance. The results suggest that there may be an
association between the antibiotic prescribing of the pri-
mary care providers and the antibiotic resistance of the
commensal S. aureus and S. pneumoniae. The role of the
primary care physicians in the appropriate prescribing is
very important to avoid the antimicrobial resistance.
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